Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.
New England Journal of Medicine.
Times cited: 876
Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: The case for aggressive management.
Journal of Clinical Oncology.
Times cited: 105